Cancer Immunotherapy Month™

June is Cancer Immunotherapy Month™. Join us in celebrating the strides made in immunotherapy research and the fight against cancer, as well as the work yet to be done.

Q2 Solutions offers novel and innovative immunotherapy laboratory services, which aim to expedite treatment of cancer. We encourage you to explore how we are leveraging our scientific expertise, innovative technologies, and industry relationships to support Immunotherapy clinical trial research.

We offer a comprehensive portfolio of genomic assays for immuno-oncology applications:

Tumor Mutational Burden
(TMB) Assay

Immune Landscape Signatures

Microsatellite Instability Assay (MSI)


With our global central laboratory network, we offer a breadth of technological expertise and harmonized processes:

 

Biomarker Testing for
Immuno-oncology Trials

The Power of the Central
Laboratory

Minimal Residual Disease


Contact us to learn more about our immunotherapy clinical development applications.